𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching from Ritonavir-Boosted Protease Inhibitors to Raltegravir

✍ Scribed by Martínez, Esteban; d'Albuquerque, Polyana M.; Pérez, Ignacio; Pich, Judit; Gatell, José M.

Book ID
118117007
Publisher
Mary Ann Liebert
Year
2013
Tongue
English
Weight
294 KB
Volume
29
Category
Article
ISSN
0889-2229

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simplification to coformulated elvitegra
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial
✍ Arribas, Jose R; Pialoux, Gilles; Gathe, Joseph; Di Perri, Giovanni; Reynes, Jac 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 260 KB